Cochlear

Cochlear FCF/Net Income

The Free Cash Flow to Net Income Ratio of Cochlear (COH.AX) as of Oct 15, 2026 is 208.35 %. In the previous year, Free Cash Flow to Net Income Ratio was 45.05 % — a change of 362.49% (higher).

FCF/Net Income

208.35 %

YoY

362.49%

Last updated:

Free Cash Flow to Net Income Ratio of Cochlear is 2026 208.35 % . Free Cash Flow to Net Income Ratio of Cochlear was 2025 45.05 % . It decreases by 362.49% higher compared to the previous year.

The Cochlear FCF/Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Net Income
Date
FCF/Net Income
Jan 1, 2019
85.33 AUD
Jan 1, 2020
120.98 AUD
Jan 1, 2021
60.86 AUD
Jan 1, 2022
103.53 AUD
Jan 1, 2023
88.66 AUD
Jan 1, 2024
91.48 AUD
Jan 1, 2025
45.05 AUD
Jan 1, 2026
208.35 AUD
The Cochlear FCF/Net Income history
YEARFCF/Net IncomeYoY
208.35 %+362.49%
45.05 %-50.75%
91.48 %+3.19%
88.66 %-14.37%
103.53 %+70.12%
60.86 %-49.70%
120.98 %+41.79%
85.33 %-8.69%
93.45 %+1.29%
92.26 %+11.54%
82.71 %-26.81%
113.00 %+20.44%
93.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Free Cash Flow to Net Income Ratio of Cochlear is 208.35 % in 2026.

Free Cash Flow to Net Income Ratio of Cochlear changed from 45.05 % to 208.35 %, representing a 362.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Net Income Ratio Cochlear since 2006 – with annual values, charts, and detailed analysis.

The FCF/Net Income ratio measures cash flow quality. Ratios consistently above 100% suggest high-quality earnings with strong cash backing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Net Income Ratio's Cochlear with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow to Net Income Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow to Net Income Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Cochlear

All Key Metrics — Cochlear